{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T12:24:18Z","timestamp":1725452658218},"reference-count":8,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.transproceed.2006.08.024","type":"journal-article","created":{"date-parts":[[2006,11,10]],"date-time":"2006-11-10T12:27:55Z","timestamp":1163161675000},"page":"2541-2543","source":"Crossref","is-referenced-by-count":12,"title":["Induction Therapy With Daclizumab in Heart Transplantation\u2014How Many Doses?"],"prefix":"10.1016","volume":"38","author":[{"given":"V.","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Almenar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mart\u00ednez-Dolz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Zorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Chamorro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Moro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ag\u00fcero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Arnau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2006.08.024_bib1","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1592\/phco.19.15.1127.30582","article-title":"A review of interleukin-2 receptor antagonist in solid organ transplantation","volume":"19","author":"Bernard","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.transproceed.2006.08.024_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.TP.0000109643.32659.C4","article-title":"Interleukin 2 receptor antagonist for renal transplant recipients: a meta-analysis of randomized trials","volume":"77","author":"Webster","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.08.024_bib3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM200003023420902","article-title":"Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody","volume":"342","author":"Beniaminovitz","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2006.08.024_bib4","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.transproceed.2004.12.135","article-title":"Daclizumab is associated with decreased rejection and no increased mortality in cardiac transplant patients receiving MMF, cyclosporine and corticosteroids","volume":"37","author":"Kobashigawa","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2006.08.024_bib5","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1016\/j.transproceed.2005.10.086","article-title":"Experience with single-dose daclizumab in the prevention of acute rejection in heart transplantation","volume":"37","author":"Cuppoletti","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2006.08.024_bib6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1399-0012.2004.00189.x","article-title":"Early experience with two-dose daclizumab in the prevention of acute rejection in cardiac transplantation","volume":"18","author":"Joyal","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2006.08.024_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00007890-199701150-00007","article-title":"A phase-1 trial of humanized anti-interleukin 2 receptor antibody in renal transplantation","volume":"63","author":"Vicenti","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.08.024_bib8","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1056\/NEJMoa032953","article-title":"Daclizumab to prevent rejection after cardiac transplantation","volume":"352","author":"Hershberger","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134506009213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134506009213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T15:51:45Z","timestamp":1547221905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134506009213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0041134506009213"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2006.08.024","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}